Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
S&P Global Appoints New Chief Legal Officer
-
Best’s Market Segment Report: AM Best Maintains Stable Outlook on Chile’s Insurance Industry
-
Watsco Schedules Third Quarter Conference Call On Tuesday, October 27, 2026 at 10:00 a.m. (EDT)
-
Energy Catalyst Launches Geothermal Energy-as-a-Service Program as Northeast Fuel Oil Prices Remain Volatile
-
Kinetic12, LLC Partners with MenuData.ai to Power Data-Driven Growth Strategy Across Foodservice, Convenience, and Retail.
-
King Copper Selects Drill Contractor for Inaugural Drill Program at Colquemayo
-
Aura Announces Preliminary Record High Production in Q3 2026 and 9M 2026 Production Results
-
Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
-
Auction result of Treasury Bonds - RIKB 29 0416 - RIKB 38 0215
-
Kinepolis completes acquisition of Showcase Cinemas, Expands its U.S. footprint with theatres in Massachusetts and New York
-
Edison Issues Report on Molecule Group (MOL)
-
Skeleton Coast Uranium Provides Update on Private Placement
-
SLAM Exploration Announces Leadership Transition and Appointment of Jimmy Gravel as President and CEO
-
Consolidated Credit Honored with American Dream Builder Award at 13th Annual Broward Entrepreneur Summit
-
Jackpot Digital and Pechanga Resort Casino Launch Eight Jackpot Blitz(R) Poker Tables, Ushering in Next Generation Poker
-
Women Legislators in 16 States Unite to Close ‘Voluntary Intoxication’ Loophole That Fails Sexual Assault Survivors
-
NeoTerrex Executes Definitive Agreement to Acquire 100% of Reservoir Copper-Gold-Silver-Tungsten Project in Québec
-
Unique AI Launches AI Teammates for Financial Services
-
We’re Not Gonna Take It: Gen X Expects a Different Senior Living Experience
-
Cyngn Autonomous Fleet Expands Operational Footprint Across Industrial Facilities in 2026
-
AlphaGraphics named to Franchise Times Top 400 for 2026
-
Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference
-
Theralase(R) to Present at ThinkEquity Conference
-
Nepra Foods Launches Flagship PROPASTA Brand on Amazon
-
Horizon Aircraft Reports Fiscal 2027 First Quarter Results and Advances Full-Scale Cavorite X7 Development
-
Hertz Energy Announces Non-Brokered Private Placement of up to $1,607,400
-
Vertical City Reaches 10,000 Elevator Screens
-
Signature Resolution Welcomes James M. Treppa to Our Panel of Neutrals
-
Signature Resolution Welcomes Hon. Carol Overton (Ret.) to Our Panel of Neutrals
-
Signature Resolution Welcomes Hon. Robert A. Brennan (Ret.) to Our Panel of Neutrals
-
Signature Resolution Welcomes Hon. Matthew J. Nestor (Ret.) to Our Panel of Neutrals
-
Metro Supply Chain Joins NX Group Following Completion of Acquisition
-
New Johnson & Johnson ICOTYDE® (icotrokinra) long-term data demonstrate robust 2-year results in the treatment of adults and adolescents with plaque psoriasis
-
Yamo Pharmaceuticals Announces Autism Trial Registry Following Global Surge in Family Interest
-
International Journal Publishes Study Linking PLC at Work® to Year-Over-Year Gains in Math and Reading in Texas Schools
-
Avient Appoints Mike Frank as Chief Executive Officer
-
X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders
-
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Amped Fitness' Much-Anticipated Amped Universe Will Officially Debut October 12 in Margate, Florida
-
Strada unveils Aon partnership and new AI-powered innovations ahead of Workday Rising U.S. 2026
-
Crunch Fitness Relocates Vancouver Plaza Gym Into an All-New Crunch 3.0 Club Next Door
-
Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical D
-
Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress
-
AT&T Delivers Value, Choice, and Flexibility with the New iPhone Duo - Backed by America's Best Guarantee.
-
Glaukos Announces Positive Topline Results from Phase 4 Prospective Randomized Controlled Clinical Trial Evaluating iDose® TR in Combination with Cataract Surgery
-
Pebblebrook Hotel Trust Completes $10.0 Million Sale of The Hotel Zags
-
Consonance Capital Partners Closes Oversubscribed Third Fund at $1.35 Billion
-
Fingerprint Ranked #1 Best Fraud Detection Software on G2, Driven by Customer Reviews
-
Avolon Orders 250 Airbus and Boeing Aircraft
-
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
